부산대학교 도서관

Lu, W-T; Zalmas, L-P; Bailey, C; Black, JRM; Martinez-Ruiz, C; Pich, O; Gimeno-Valiente, F; Usaite, I; Magness, A; Thol, K

NATURE CELL BIOLOGY. 27(1):154-168

Bruixola G; Department of Medical Oncology, INCLIVA Biomedical Research Institute, Hospital Clínico Universitario de Valencia, University of Valencia, Valencia, Spain.; Martín-Arana J; Department of Medical Oncology, INCLIVA Biomedical Research Institute, Hospital Clínico Universitario de Valencia, University of Valencia, Valencia, Spain; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Gimeno-Valiente F; Cancer Evolution and Genome Instability Laboratory, University College London Cancer Institute, London, UK.; Carbonell-Asins JA; Biostatistics Unit, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; García-Micó B; Department of Medical Oncology, INCLIVA Biomedical Research Institute, Hospital Clínico Universitario de Valencia, University of Valencia, Valencia, Spain; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Martínez-Castedo B; Department of Medical Oncology, INCLIVA Biomedical Research Institute, Hospital Clínico Universitario de Valencia, University of Valencia, Valencia, Spain; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; González-Camblor D; Department of Medical Oncology, INCLIVA Biomedical Research Institute, Hospital Clínico Universitario de Valencia, University of Valencia, Valencia, Spain; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Grimalt N; Department of Medical Oncology, INCLIVA Biomedical Research Institute, Hospital Clínico Universitario de Valencia, University of Valencia, Valencia, Spain.; García-Bartolomé M; Department of Medical Oncology, INCLIVA Biomedical Research Institute, Hospital Clínico Universitario de Valencia, University of Valencia, Valencia, Spain.; Alfaro-Cervelló C; Department of Pathology, INCLIVA Biomedical Research Institute, Hospital Clínico Universitario de Valencia, University of Valencia, Valencia, Spain.; Escorihuela V; Otorhinolaryngology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.; Iglesias ME; Oral and Maxillary Surgery Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.; Maroñas M; Radiation Oncology Department, Hospital Clinico Universitario de Valencia, University of Valencia, Valencia, Spain.; Dualde D; Radiology Department, Hospital Clinico Universitario de Valencia, University of Valencia, Valencia, Spain.; Cervantes A; Department of Medical Oncology, INCLIVA Biomedical Research Institute, Hospital Clínico Universitario de Valencia, University of Valencia, Valencia, Spain; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain. Electronic address: andres.cervantes@uv.es.; Tarazona N; Department of Medical Oncology, INCLIVA Biomedical Research Institute, Hospital Clínico Universitario de Valencia, University of Valencia, Valencia, Spain; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain. Electronic address: noetalla@incliva.es.

Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Prieto-de-la-Lastra C; Quantitative Imaging Biomarkers in Medicine, Quibim S.L., Madrid, Spain; Medical Image Analysis and Biometry Laboratory, Universidad Rey Juan Carlos, Madrid, Spain.; Carbonell-Asins JA; Biostatistics Unit, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; Bueno A; Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; Quantitative Imaging Biomarkers in Medicine, Quibim S.L., Valencia, Spain.; Gómez-Alderete A; Department of Medical Oncology, Hospital del Mar Research Institute, Universitat Pompeu Fabra, Barcelona, Spain.; Busto M; Department of Radiology, Hospital del Mar Research Institute-IMIM, Universitat Pompeu Fabra, Barcelona, Spain.; Alcolado-Jaramillo AB; Department of Radiology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, Valencia, Spain.; Jimenez-Pastor A; Quantitative Imaging Biomarkers in Medicine, Quibim S.L., Valencia, Spain.; Monzonís X; Hospital del Mar Research Institute, Barcelona, Spain.; Cuñat A; Department of Radiology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, Valencia, Spain.; Montagut C; Department of Medical Oncology, Hospital del Mar Research Institute, Universitat Pompeu Fabra, Barcelona, Spain; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Moreno-Ruiz P; Quantitative Imaging Biomarkers in Medicine, Quibim S.L., Valencia, Spain.; Huerta M; Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Roda D; Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Gimeno-Valiente F; Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; Estepa-Fernández A; Quantitative Imaging Biomarkers in Medicine, Quibim S.L., Valencia, Spain.; Bellvís-Bataller F; Quantitative Imaging Biomarkers in Medicine, Quibim S.L., Valencia, Spain.; Fuster-Matanzo A; Quantitative Imaging Biomarkers in Medicine, Quibim S.L., Valencia, Spain.; Gibert J; Hospital del Mar Research Institute, Barcelona, Spain.; Roselló S; Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Martinez-Ciarpaglini C; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain; Department of Pathology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; Vidal J; Department of Medical Oncology, Hospital del Mar Research Institute, Universitat Pompeu Fabra, Barcelona, Spain; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Alberich-Bayarri Á; Quantitative Imaging Biomarkers in Medicine, Quibim S.L., Valencia, Spain.; Cervantes A; Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain. Electronic address: andres.cervantes@uv.es.; Tarazona N; Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain. Electronic address: noetalla@incliva.es.

Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Martínez-Castedo B; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; CIBERONC, Carlos III Health Institute, Madrid, Spain.; Camblor DG; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; Martín-Arana J; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; CIBERONC, Carlos III Health Institute, Madrid, Spain.; Carbonell-Asins JA; Biostatistics Unit, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; García-Micó B; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; CIBERONC, Carlos III Health Institute, Madrid, Spain.; Gambardella V; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; Huerta M; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; CIBERONC, Carlos III Health Institute, Madrid, Spain.; Roselló S; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; CIBERONC, Carlos III Health Institute, Madrid, Spain.; Roda D; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; CIBERONC, Carlos III Health Institute, Madrid, Spain.; Gimeno-Valiente F; Cancer Evolution and Genome Instability Laboratory, University College London Cancer Institute, London, UK.; Cervantes A; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; CIBERONC, Carlos III Health Institute, Madrid, Spain. Electronic address: andres.cervantes@uv.es.; Tarazona N; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; CIBERONC, Carlos III Health Institute, Madrid, Spain. Electronic address: noetalla@incliva.es.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Tarazona, N; Gimeno-Valiente, F; Gambardella, V; Zuñiga, S; Rentero-Garrido, P; Huerta, M; Roselló, S; Martinez-Ciarpaglini, C; Carbonell-Asins, J A; Carrasco, F; Ferrer-Martínez, A; Bruixola, G; Fleitas, T; Martín, J; Tébar-Martínez, R; Moro, D; Castillo, J; Espí, A; Roda, D; Cervantes, A

Annals of Oncology. Nov2019, Vol. 30 Issue 11, p1804-1812. 9p. 1 Diagram, 1 Chart, 5 Graphs.

Gambardella, V; Fleitas, T; Tarazona, N; Cejalvo, J M; Gimeno-Valiente, F; Martinez-Ciarpaglini, C; Huerta, M; Roselló, S; Castillo, J; Roda, D; Cervantes, A

Annals of Oncology. Aug2019, Vol. 30 Issue 8, p1254-1264. 11p. 2 Color Photographs, 1 Diagram, 2 Charts, 1 Graph.

Badia-Ramentol, J; Gimeno-Valiente, F; Duréndez, E; Martínez-Ciarpaglini, C; Linares, J; Iglesias, M; Cervantes, A; Calon, A; Tarazona, N

Cancer Treatment Reviews. 121:102643

Gimeno-Valiente F; Cancer Evolution and Genome Instability Laboratory, University College London Cancer Institute, London, UK.; Martín-Arana J; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia; CIBERONC, Instituto de Salud Carlos III, Madrid.; Tébar-Martínez R; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia.; Gambardella V; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia.; Martínez-Ciarpaglini C; CIBERONC, Instituto de Salud Carlos III, Madrid; Department of Pathology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia.; García-Micó B; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia; CIBERONC, Instituto de Salud Carlos III, Madrid.; Martínez-Castedo B; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia; CIBERONC, Instituto de Salud Carlos III, Madrid.; Palomar B; Department of Pathology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia.; García-Bartolomé M; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia.; Seguí V; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia.; Huerta M; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia.; Moro-Valdezate D; Colorectal Surgery Unit, INCLIVA Biomedical Research Institute, Hospital Clínico Universitario de Valencia, Department of Surgery, University of Valencia, Valencia, Spain.; Pla-Martí V; Colorectal Surgery Unit, INCLIVA Biomedical Research Institute, Hospital Clínico Universitario de Valencia, Department of Surgery, University of Valencia, Valencia, Spain.; Pérez-Santiago L; Colorectal Surgery Unit, INCLIVA Biomedical Research Institute, Hospital Clínico Universitario de Valencia, Department of Surgery, University of Valencia, Valencia, Spain.; Roselló S; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia; CIBERONC, Instituto de Salud Carlos III, Madrid.; Roda D; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia; CIBERONC, Instituto de Salud Carlos III, Madrid.; Cervantes A; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia; CIBERONC, Instituto de Salud Carlos III, Madrid. Electronic address: andres.cervantes@uv.es.; Tarazona N; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia; CIBERONC, Instituto de Salud Carlos III, Madrid. Electronic address: noetalla@incliva.es.

Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Gambardella V; Department of Medical Oncology, Biomedical Research Institute INCLIVA, University of Valencia, Valencia; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Gimeno-Valiente F; Cancer Evolution and Genome Instability Laboratory, University College of London Cancer Institute, London, UK.; Roselló S; Department of Medical Oncology, Biomedical Research Institute INCLIVA, University of Valencia, Valencia; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Cervantes A; Department of Medical Oncology, Biomedical Research Institute INCLIVA, University of Valencia, Valencia; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain. Electronic address: andres.cervantes@uv.es.

Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE; PubMed not MEDLINE

Tarazona N; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Madrid, Spain; Instituto de Salud Carlos III, CIBERONC, Madrid, Spain. Electronic address: noetalla@incliva.es.; Gimeno-Valiente F; Cancer Evolution and Genome Instability Laboratory, University College London Cancer Institute, London, UK.; Cervantes A; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Madrid, Spain; Instituto de Salud Carlos III, CIBERONC, Madrid, Spain.

Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Gambardella V; Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Cejalvo JM; Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; González-Barrallo I; Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; Gimeno-Valiente F; Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; University College London School of Life and Medical Sciences, Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cervantes A; Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain. Electronic address: andres.cervantes@uv.es.

Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE; PubMed not MEDLINE

Papaccio, F; Gutierrez-Bravo, MF; Cabeza-Segura, M; Gambardella, V; Huerta, M; Ciarpaglini, CM; Keranen, SR; Gimeno-Valiente, F; Fleitas, T; Llavero, NT; Roda, D; Cervantes, A; Castillo, J

Annals of Oncology. 30:v240-v241

Gambardella V; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; Instituto de Salud Carlos III, CIBERONC, Madrid, Spain.; Castillo J; Department of Biochemistry and Molecular Biology, University of Valencia, Valencia, Spain.; Tarazona N; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; Instituto de Salud Carlos III, CIBERONC, Madrid, Spain.; Gimeno-Valiente F; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; Martínez-Ciarpaglini C; Instituto de Salud Carlos III, CIBERONC, Madrid, Spain; Department of Pathology, INCLIVA Biomedical Research Institute, Spain.; Cabeza-Segura M; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; Roselló S; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; Instituto de Salud Carlos III, CIBERONC, Madrid, Spain.; Roda D; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; Instituto de Salud Carlos III, CIBERONC, Madrid, Spain.; Huerta M; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; Cervantes A; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; Instituto de Salud Carlos III, CIBERONC, Madrid, Spain.; Fleitas T; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; Instituto de Salud Carlos III, CIBERONC, Madrid, Spain. Electronic address: tfleitas@incliva.es.

Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7502030 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1967 (Electronic) Linking ISSN: 03057372 NLM ISO Abbreviation: Cancer Treat Rev Subsets: MEDLINE

Llavero, NT; Gimeno-Valiente, F; Gambardella, V; Huerta, M; Keranen, SR; Bruixola, G; Fontana, E; Ciarpaglini, CM; Zuñiga, S; Rentero, P; Fleitas, T; Papaccio, F; Moro, D; Pla, V; Nyamundanda, G; Castillo, J; Sadanadam, A; Espí, A; Roda, D; Cervantes, A

Annals of Oncology. 30:v198

Gimeno-Valiente F; Institute of Health Research, INCLIVA, Valencia, Spain.; Riffo-Campos ÁL; Institute of Health Research, INCLIVA, Valencia, Spain.; Departamento de Anatomía Patológica. Universidad de La Frontera, Temuco, Chile.; Ayala G; Department of Statistics and Operational Research, University of Valencia, Burjassot, Valencia, Spain.; Tarazona N; Institute of Health Research, INCLIVA, Valencia, Spain.; Department of Medical Oncology, University Hospital, Universitat de València, Valencia, Spain.; Gambardella V; Institute of Health Research, INCLIVA, Valencia, Spain.; Department of Medical Oncology, University Hospital, Universitat de València, Valencia, Spain.; Rodríguez FM; Institute of Health Research, INCLIVA, Valencia, Spain.; Instituto De Ciencias Veterinarias Del Litoral (ICIVET Litoral), Universidad Nacional Del Litoral (UNL)/Consejo Nacional De Investigaciones Científicas Y Técnicas (CONICET), Santa Fe, Argentina.; Huerta M; Institute of Health Research, INCLIVA, Valencia, Spain.; Department of Medical Oncology, University Hospital, Universitat de València, Valencia, Spain.; Martínez-Ciarpaglini C; Institute of Health Research, INCLIVA, Valencia, Spain.; Department of Medical Oncology, University Hospital, Universitat de València, Valencia, Spain.; Montón-Bueno J; Department of Medical Oncology, University Hospital, Universitat de València, Valencia, Spain.; Roselló S; Institute of Health Research, INCLIVA, Valencia, Spain.; Department of Medical Oncology, University Hospital, Universitat de València, Valencia, Spain.; Centro de Investigación Biomédica en Red en Cáncer (CIBERONC), Madrid, Spain.; Roda D; Institute of Health Research, INCLIVA, Valencia, Spain.; Department of Medical Oncology, University Hospital, Universitat de València, Valencia, Spain.; Centro de Investigación Biomédica en Red en Cáncer (CIBERONC), Madrid, Spain.; Cervantes A; Institute of Health Research, INCLIVA, Valencia, Spain.; Department of Medical Oncology, University Hospital, Universitat de València, Valencia, Spain.; Centro de Investigación Biomédica en Red en Cáncer (CIBERONC), Madrid, Spain.; Franco L; Institute of Health Research, INCLIVA, Valencia, Spain. luis.franco@uv.es.; Department of Biochemistry and Molecular Biology, Universitat de València, Valencia, Spain. luis.franco@uv.es.; López-Rodas G; Institute of Health Research, INCLIVA, Valencia, Spain.; Department of Biochemistry and Molecular Biology, Universitat de València, Valencia, Spain.; Castillo J; Institute of Health Research, INCLIVA, Valencia, Spain.; Centro de Investigación Biomédica en Red en Cáncer (CIBERONC), Madrid, Spain.; Department of Biochemistry and Molecular Biology, Universitat de València, Valencia, Spain.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

Cabeza, M; Papaccio, F; Bravo, MFG; Gambardella, V; Alfaro-Cervello, C; Martínez-Ciarpaglini, C; Garzón-Lloría, Z; Rentero-Garrido, P; Zúñiga-Trejos, S; Seda-García, E; Gimeno-Valiente, F; Peña, A; Barrios, M; Tarazona, N; Roda, D; Cervantes, A; Fleitas, T; Castillo, J

Papaccio, F; Bravo, MFG; Cabeza-Segura, M; Gimeno-Valiente, F; Gambardella, V; Garzón-Lloría, Z; García-Micó, B; Huerta, M; Martínez-Ciarpaglini, C; Alfaro-Cervello, C; Sabater, L; Lombardi, P; Rentero-Garrido, P; Zúñiga-Trejos, S; Keränen, SR; Fleitas, T; Tarazona, N; Roda, D; Cervantes, A; Castillo, J